LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
Xi Jin(First Affiliated Hospital Zhejiang University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University)
Cited by 92
Related Papers
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
|Cell Reports Medicine|2022|92